Among critically ill patients, severe pulmonary and extrapulmonary tuberculosis has high
morbidity and mortality. Yet, it is a diagnostic challenge given its nonspecific clinical …

The pathogenesis of immune thrombocytopenia (ITP) is complex and involves the
dysregulation of immune cells, such as T and B lymphocytes, and several cytokines that …

Tuberculosis is a chronic granulomatous inflammation highly prevalent in developing
countries resulting in high mortality rate. The study was conducted to investigate the change …

Non-dystrophic myotonias (NDM) manifest as delayed muscle relaxation leading to muscle
stiffness. This may diminish or worsen with repeated contractions, depending on NDM …

Interventions: Both patients received anti-infection therapy, platelet transfusions, and
intravenous immunoglobulins. Moreover, Patient 2 also received antituberculosis treatment …

Currently, the only option for treating brucellosis is antibiotics especially to prevent
complications. In this chapter, we want to talk about the drug therapy in brucellosis and the …

Drug-induced thrombocytopenia occurs through immune-mediated platelet destruction, and
its management is challenging during tuberculosis treatment. Although rifampicin is the most …

Tuberculosis is a potentially treatable infectious disease caused by Mycobacterium
tuberculosis Complex. Pulmonary presentation is the most frequent, with nonpulmonary …

1. Rawat J, Sindhwani G, Biswas D. Effect of age on presentation with diabetes: Comparison
of nondiabetic patients with new smear-positive pulmonary tuberculosis patients. Lung India …

Severe immune thrombocytopenia is a rare side-effect of rifampicin (RFP) and can be life-
threatening. Here, we report the case of a 74-year-old male with tuberculous pleurisy who …